High-grade Serous Ovarian Carcinoma (HGSOC) Completed Phase Trials for Anlotinib (DB11885)

Also known as: B. High Grade Serous Ovarian Cancer / Ovarian High Grade Serous Carcinoma / High-grade Serous Ovarian Cancer / High-grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Carcinoma / High Grade Serous Ovarian Cancer / High Grade Ovarian Serous / High Grade Serous Ovarian

IndicationStatusPhase
DBCOND0140551 (High-grade Serous Ovarian Carcinoma (HGSOC))CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05188781Pembrolizumab and Anlotinib in the Treatment of High-Grade Serous Ovarian Cancer